What drives MDG1.F stock moves right now?

MDG1.F stock moves are driven mainly by the company liquidation process and episodic trading in a thin market. News on asset sales or distributions and the 26 Mar 2026 earnings update are key triggers.

How does Meyka AI grade MDG1.F stock affect investors?

Meyka AI rates MDG1.F with a score of 62.71 out of 100 and a B grade with a HOLD suggestion. The grade factors sector and benchmark comparison, growth, key metrics, and consensus data.

What is the short-term forecast for MDG1.F stock?

Meyka AI's forecast model projects a monthly level of €0.01 for MDG1.F stock. This model-based projection implies a sizeable downside versus the current €0.037 and is not a guarantee.

Should I trade MDG1.F stock before the earnings date?

Trading MDG1.F stock before the 26 Mar 2026 earnings notice carries high liquidity and event risk. Use small sizes and limit orders. Expect price sensitivity to any liquidation progress updates.

DE Stocks

MDG1.F Medigene AG (XETRA) up 8.09% pre-market 26 Feb 2026: monitor liquidation updates

ByDanny Kontos February 26, 2026

MDG1.F stock rose 8.09% in pre-market trading on 26 Feb 2026, trading at €0.037 on XETRA after an early bid and low volume. The move follows continued investor attention to Medigene AG as the company winds down operations and liquidates remaining assets. Volume of 4,555 shares remains below the 50-day average of 13,260, so the spike looks speculative rather than broad-based. Traders should weigh the liquidation context and upcoming earnings notice when assessing short-term risk.